Case of Extensively Drug-Resistant Shigella sonnei Infection, United States

Emerg Infect Dis. 2023 Aug;29(8):1708-1711. doi: 10.3201/eid2908.230411.

Abstract

We report extensively drug-resistant (XDR) Shigella sonnei infection in an immunocompromised patient in Texas, USA. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry failed to identify XDR Shigella, but whole-genome sequencing accurately characterized the strain. First-line antimicrobials are not effective against emerging XDR Shigella. Fosfomycin, carbapenems, and tigecycline are potential alternatives.

Keywords: MSM; Shigella sonnei; United States; XDR Shigella; antimicrobial resistance; bacteria; enteric infections; extensively drug-resistant Shigella; men who have sex with men; sexually transmitted infections; whole-genome sequencing.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Anti-Infective Agents* / pharmacology
  • Dysentery, Bacillary* / diagnosis
  • Dysentery, Bacillary* / drug therapy
  • Dysentery, Bacillary* / epidemiology
  • Humans
  • Microbial Sensitivity Tests
  • Shigella sonnei / genetics
  • Shigella*
  • United States / epidemiology

Substances

  • Anti-Bacterial Agents
  • Anti-Infective Agents